Grants per year
Personal profile
Education/Academic qualification
PHD, University of California-Irvine
… → 2003
BS, Harvey Mudd College
… → 1998
Fingerprint
Dive into the research topics where Carl Wagner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 8 Finished
-
Assessing Novel Rexinoids Developed by Comparative Bioresponse Analysis in an Innovative Mouse Model of Cutaneous T Cell Lymphoma
Marshall, P. (CoI), Wagner, C. (PI) & Jurutka, P. (CoI)
HHS: National Institutes of Health (NIH)
5/1/20 → 4/30/24
Project: Research project
-
New College Environmental Health Science Scholars - A Unique Summer Program Designed to Increase Diversity in the Environmental Health Sciences
Marshall, P. (PI), Wagner, C. (CoI), Solis, F. (CoI), Jurutka, P. (CoI), Johnson, C. (CoI), Ferry, L. (CoI), Sandrin, T. (CoI), Ball, B. (CoI), Hackney Price, J. (CoI), Watanabe, K. (CoI), Cahill, T. (CoI), Polidoro, B. (CoI) & Shah, D. (CoI)
HHS: National Institutes of Health (NIH)
2/1/19 → 1/31/24
Project: Research project
-
Identifying Novel Rexinoids that Enhance ApoE Expression and Promote Amyloid- Beta Clearance
Wagner, C. (PI), Marshall, P. (CoI) & Jurutka, P. (CoI)
7/1/18 → 7/1/21
Project: Research project
-
Development of Next Generation Therapeutics to Combat Alzheimers Dementia and Neurodegenerative Disorders (ASUF 30000770)
Wagner, C. (PI), Marshall, P. (CoI) & Jurutka, P. (CoI)
6/1/15 → 5/31/16
Project: Research project
-
Collaborative Research: A Two-Year CollegeFour-Year University Parternership to Transform Chemistry and Biotechnology Curricula using FT-NMR
Sandrin, T. (PI) & Wagner, C. (CoI)
National Science Foundation (NSF)
9/1/11 → 8/31/15
Project: Research project
-
Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas
Warda, A., Staniszewski, L. J. P., Sabir, Z., Livingston, S., Sausedo, M., Reshi, S., Ron, E., Applegate, M. T., Haddad, D., Khamisi, M., Marshall, P. A., Wagner, C. E. & Jurutka, P. W., Nov 2023, In: Cells. 12, 21, 2575.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene
Jurutka, P. W., di Martino, O., Reshi, S., Mallick, S., Sausedo, M. A., Moen, G. A., Lee, I. J., Ivan, D. J., Krall, T. D., Peoples, S. J., Perez, A., Tromba, L., Le, A., Khadka, I., Petros, R., Savage, B. M., Salama, E., Salama, J., Ziller, J. W. & Noh, Y. & 5 others, , Dec 2022, In: International journal of molecular sciences. 23, 24, 16213.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Rexinoids Modulate Effector T Cell Expression of Mucosal Homing Markers CCR9 and α4β7 Integrin and Direct Their Migration In Vitro
Manhas, K. R., Marshall, P. A., Wagner, C. E., Jurutka, P. W., Mancenido, M. V., Debray, H. Z. & Blattman, J. N., Jan 27 2022, In: Frontiers in immunology. 13, 746484.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer
Reich, L. A., Moerland, J. A., Leal, A. S., Zhang, D., Carapellucci, S., Lockwood, B., Jurutka, P. W., Marshall, P. A., Wagner, C. E. & Liby, K. T., Dec 2022, In: Scientific reports. 12, 1, 293.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Endogenous and combination retinoids are active in myelomonocytic leukemias
di Martino, O., Niu, H., Hadwiger, G., Kuusanmaki, H., Ferris, M. A., Vu, A., Beales, J., Wagner, C., Menéndez-Gutiérrez, M. P., Ricote, M., Heckman, C. & Welch, J. S., Apr 2021, In: Haematologica. 106, 4, p. 1008-1021 14 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations
Press/Media
-
Flinn Foundation Funds Arizona Research Teams to Drive Discoveries Into Clinical Settings
Krajmalnik-Brown, R., Ugarova, T. & Wagner, C.
1/4/24
1 item of Media coverage
Press/Media: Press / Media
-
Research on Cutaneous T-Cell Lymphoma Described by a Researcher at Arizona State University (Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas)
Jurutka, P., Marshall, P. & Wagner, C.
11/20/23
1 item of Media coverage
Press/Media: Press / Media
-
New Antineoplastics Research from Arizona State University Outlined [An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene]
Jurutka, P., Marshall, P. & Wagner, C.
1/9/23
1 item of Media coverage
Press/Media: Press / Media
-
US Patent Issued to Arizona Board of Regents on behalf of Arizona State University on Oct. 4 for "Pharmaceutical compositions comprising caffeic acid chelates" (Arizona Inventors)
Jacobs, B., Cahill, T., Wagner, C. & Langland, J.
10/5/22
1 item of Media coverage
Press/Media: Press / Media
-
Educators consider the future of higher education as enrollment declines
5/13/22
1 item of Media coverage
Press/Media: Press / Media